Literature DB >> 24041898

Carbapenemase-producing enterobacteriaceae in Spain in 2012.

Jesús Oteo1, David Saez, Verónica Bautista, Sara Fernández-Romero, Juan Manuel Hernández-Molina, María Pérez-Vázquez, Belén Aracil, José Campos.   

Abstract

We report the epidemiological impact of carbapenemase-producing Enterobacteriaceae (CPE) in Spain in 2012. Of the 237 carbapenemases detected, 163 were from the OXA-48 group, 60 were from VIM-1, 8 were from KPC-2, 5 were from IMP, and 1 was from NDM-1. Interhospital spread of carbapenemase-producing Klebsiella pneumoniae was due to a limited number of multilocus sequence types (MLST) and carbapenemase types, including ST15-VIM-1, ST11-OXA-48, ST405-OXA-48, ST101-KPC-2, and ST11-VIM-1. The number of CPE cases in Spain has increased sharply in recent years, due mainly to the emergence of OXA-48.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24041898      PMCID： PMC3837857          DOI： 10.1128/AAC.01513-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals.

Authors:  Youri Glupczynski; Te-Din Huang; Warda Bouchahrouf; Roberta Rezende de Castro; Caroline Bauraing; Michèle Gérard; Anne-Marie Verbruggen; Ariane Deplano; Olivier Denis; Pierre Bogaerts
Journal:  Int J Antimicrob Agents       Date:  2011-11-23       Impact factor: 5.283

Review 2.  Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.

Authors:  R Cantón; M Akóva; Y Carmeli; C G Giske; Y Glupczynski; M Gniadkowski; D M Livermore; V Miriagou; T Naas; G M Rossolini; Ø Samuelsen; H Seifert; N Woodford; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2012-05       Impact factor: 8.067

3.  Detection of KPC-2-producing Citrobacter freundii isolates in Spain.

Authors:  María Rosa Gómez-Gil; José Ramón Paño-Pardo; María Pilar Romero-Gómez; Mercedes Gasior; María Lorenzo; Inmaculada Quiles; Jesús Mingorance
Journal:  J Antimicrob Chemother       Date:  2010-09-16       Impact factor: 5.790

4.  Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

Authors:  Isabel Sánchez-Romero; Angel Asensio; Jesús Oteo; María Muñoz-Algarra; Beatriz Isidoro; Ana Vindel; José Alvarez-Avello; Bárbara Balandín-Moreno; Oscar Cuevas; Sara Fernández-Romero; Luisa Azañedo; David Sáez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

5.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit.

Authors:  Jesús Oteo; José Luis Hernández-Almaraz; Javier Gil-Antón; Ana Vindel; Sara Fernández; Verónica Bautista; José Campos
Journal:  Pediatr Infect Dis J       Date:  2010-12       Impact factor: 2.129

Review 7.  Carbapenem resistance in Enterobacteriaceae: here is the storm!

Authors:  Patrice Nordmann; Laurent Dortet; Laurent Poirel
Journal:  Trends Mol Med       Date:  2012-04-03       Impact factor: 11.951

Review 8.  Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.

Authors:  Neil Woodford; Jane F Turton; David M Livermore
Journal:  FEMS Microbiol Rev       Date:  2011-03-01       Impact factor: 16.408

9.  Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?

Authors:  M Tato; T M Coque; P Ruíz-Garbajosa; V Pintado; J Cobo; H S Sader; R N Jones; F Baquero; R Cantón
Journal:  Clin Infect Dis       Date:  2007-09-27       Impact factor: 9.079

10.  Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011.

Authors:  T Giani; B Pini; F Arena; V Conte; S Bracco; R Migliavacca; A Pantosti; L Pagani; F Luzzaro; G M Rossolini
Journal:  Euro Surveill       Date:  2013-05-30
View more
  37 in total

1.  Rapid Detection of OXA-48-Producing Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Marina Oviaño; Maria José Barba; Begoña Fernández; Adriana Ortega; Belén Aracil; Jesús Oteo; José Campos; Germán Bou
Journal:  J Clin Microbiol       Date:  2015-12-16       Impact factor: 5.948

2.  Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.

Authors:  María Pérez-Vazquez; Jesús Oteo-Iglesias; Pedro J Sola-Campoy; Hugo Carrizo-Manzoni; Verónica Bautista; Noelia Lara; Belén Aracil; Almudena Alhambra; Luis Martínez-Martínez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35.

Authors:  Mariana Castanheira; Sarah E Costello; Leah N Woosley; Lalitagauri M Deshpande; Todd A Davies; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

4.  Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012.

Authors:  Javier Fernández; Ignacio Montero; Ana Fleites; M Rosario Rodicio
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

5.  Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.

Authors:  Jesús Oteo; Adriana Ortega; Rosa Bartolomé; Germán Bou; Carmen Conejo; Marta Fernández-Martínez; Juan José González-López; Laura Martínez-García; Luis Martínez-Martínez; María Merino; Elisenda Miró; Marta Mora; Ferran Navarro; Antonio Oliver; Álvaro Pascual; Jesús Rodríguez-Baño; Guillermo Ruiz-Carrascoso; Patricia Ruiz-Garbajosa; Laura Zamorano; Verónica Bautista; María Pérez-Vázquez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

6.  Tracking Nosocomial Klebsiella pneumoniae Infections and Outbreaks by Whole-Genome Analysis: Small-Scale Italian Scenario within a Single Hospital.

Authors:  Raffaella Onori; Stefano Gaiarsa; Francesco Comandatore; Stefano Pongolini; Sylvain Brisse; Alberto Colombo; Gianluca Cassani; Piero Marone; Paolo Grossi; Giulio Minoja; Claudio Bandi; Davide Sassera; Antonio Toniolo
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

7.  The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3.

Authors:  Jesús Oteo; María Pérez-Vázquez; Verónica Bautista; Adriana Ortega; Pilar Zamarrón; David Saez; Sara Fernández-Romero; Noelia Lara; Raquel Ramiro; Belén Aracil; José Campos
Journal:  J Antimicrob Chemother       Date:  2016-08-15       Impact factor: 5.790

8.  Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.

Authors:  Leonardo Neves Andrade; Lúcia Vitali; Gilberto Gambero Gaspar; Fernando Bellissimo-Rodrigues; Roberto Martinez; Ana Lúcia Costa Darini
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

9.  OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland.

Authors:  Salome N Seiffert; Vincent Perreten; Sönke Johannes; Sara Droz; Thomas Bodmer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

10.  Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.

Authors:  P Garcinuño; M Santibañez; L Gimeno; A Sánchez-Bautista; J Coy; J Sánchez-Paya; V Boix; E Merino; J Portilla; J C Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-09       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.